X0202 SCHEDULE 13G 0001232258 XXXXXXXX LIVE Common Shares, no par value 06/30/2026 0002124403 Vicore Pharma Holding AB 92581R104 Kornhamnstorg 53 Stockholm V7 SE-111 27 Rule 13d-1(d) HBM Healthcare Investments (Cayman) Ltd. E9 22505819.00 0.00 22505819.00 0.00 22505819.00 N 8 CO Voting and investment power over the shares held by HBM Healthcare Investments (Cayman) Ltd. is exercised by the board of directors of HBM Healthcare Investments (Cayman) Ltd. (the "Board"). The Board consists of Jean-Marc LeSieur, Richard H. Coles, Sophia Harris, Dr. Andreas Wicki, Mark Kronenfeld, M.D., and Richard Paul Woodhouse, none of whom has individual voting or investment power with respect to the shares. Vicore Pharma Holding AB Kornhamnstorg 53, SE-111 27, Stockholm, Sweden HBM Healthcare Investments (Cayman) Ltd. (the "Reporting Person") Governors Square, 23 Lime Tree Bay Avenue, PO Box 30852, Grand Cayman, KY1-1204, Cayman Islands Cayman Islands, British West Indies Y The CUSIP provided in this statement is the CUSIP for the Issuer's American Depositary Shares ("ADSs"). Each one ADS represents ten (10) Common shares, no par value, of the Issuer ("Common Shares"). The ADSs are not deemed a separate class of securities for purposes of calculating beneficial ownership under Section 13(d) of the Securities Exchange Act of 1934, as amended. Accordingly, the Reporting Person's beneficial ownership is reported in this Schedule 13G in terms of Common Shares, not ADSs. However, the CUSIP provided in this statement is the CUSIP for the Issuer's ADSs because there is no CUSIP number assigned to the Common Shares. As of June 30, 2026, the Reporting Person may have been deemed the beneficial owner of 22,687,752 Common Shares. As of the date hereof, the Reporting Person may be deemed the beneficial owner of 22,505,819 Common Shares. As of June 30, 2026, the Reporting Person may have been deemed the beneficial owner of approximately 8.1% of the Common Shares outstanding, based on 281,525,593 Common Shares outstanding as of June 30, 2026, as reported in Exhibit 99.1 to the Issuer's current report on Form 6-K filed with the Securities and Exchange Commission on August 21, 2026. As of the date hereof, the Reporting Person may be deemed the beneficial owner of approximately 8% of the Common Shares outstanding. The percentage set forth herein is calculated based on 281,644,509 Common Shares outstanding as of September 30, 2026, as reported in Exhibit 99.1 to the Issuer's current report on Form 6-K filed with the Securities and Exchange Commission on September 30, 2026. 22,505,819 0 22,505,819 0 Y Y Y Y Y Y HBM Healthcare Investments (Cayman) Ltd. /s/ Jean-Marc LeSieur 10/13/2026